1 ANNEX, Regulation (EU) 2018/675

In forcesince 2 May 2018

Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:

(1)

Column 1 of entries 28 to 30 is replaced by the following:

‘28. | Substances which are classified as carcinogen category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 1 or Appendix 2, respectively.

29.

| Substances which are classified as germ cell mutagen category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 3 or Appendix 4, respectively.

30.

| Substances which are classified as reproductive toxicant category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 5 or Appendix 6, respectively.’

(2)

In Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein:

‘2,3-epoxypropyl methacrylate;

glycidyl methacrylate

607-123-00-4 | 203-441-9 | 106-91-2 |

cadmium carbonate | 048-012-00-5 | 208-168-9 | 513-78-0 |

cadmium hydroxide; cadmium dihydroxide | 048-013-00-0 | 244-168-5 | 21041-95-2 |

cadmium nitrate; cadmium dinitrate | 048-014-00-6 | 233-710-6 | 10325-94-7 |

formaldehyde … % | 605-001-00-5 | 200-001-8 | 50-00-0 |

anthraquinone | 606-151-00-4 | 201-549-0 | 84-65-1 |

N,N′-methylenedimorpholine;

N,N′-methylenebismorpholine;

[formaldehyde released from N,N′-methylenebismorpholine];

[MBM]

607-721-00-5 | 227-062-3 | 5625-90-1 |

reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2);

[formaldehyde released from 3,3′-methylenebis[5-methyloxazolidine];

formaldehyde released from oxazolidin];

[MBO]

612-290-00-1 | — | — |

reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1);

[formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol];

[HPT]

612-291-00-7 | — | — |

methylhydrazine | 612-292-00-2 | 200-471-4 | 60-34-4’ |

(3)

In Appendix 4, the following entries are inserted in the table in order of the index numbers set out therein:

‘cadmium carbonate | 048-012-00-5 | 208-168-9 | 513-78-0 |

cadmium hydroxide; cadmium dihydroxide | 048-013-00-0 | 244-168-5 | 21041-95-2 |

cadmium nitrate; cadmium dinitrate | 048-014-00-6 | 233-710-6 | 10325-94-7’ |

(4)

In Appendix 6, the following entries are inserted in the table in order of the index numbers set out therein:

‘2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one | 606-041-00-6 | 400-600-6 | 71868-10-5 |

2,3-epoxypropyl methacrylate;

glycidyl methacrylate

607-123-00-4 | 203-441-9 | 106-91-2 |

cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | 650-032-00-X | — | 94361-06-5 |

dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)]stannane | 050-030-00-3 | 201-039-8 | 77-58-7 |

nonadecafluorodecanoic acid; [1]

ammonium nonadecafluorodecanoate; [2]

sodium nonadecafluorodecanoate [3]

607-720-00-X |

206-400-3 [1]

221-470-5 [2]

[3]

335-76-2 [1]

3108-42-7 [2]

3830-45-3 [3]

triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;

α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol

613-322-00-7 | 259-537-6 | 55219-65-3 |

quinolin-8-ol;

8-hydroxyquinoline

613-324-00-8 | 205-711-1 | 148-24-3 |

thiacloprid (ISO);

(Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide;

{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide

613-325-00-3 | — | 111988-49-9 |

carbetamide (ISO);

(R)-1-(ethylcarbamoyl)ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate

616-223-00-7 | 240-286-6 | 16118-49-3’ |